Skip to main content

Table 5 Direction of influence on SR conclusions

From: A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project

 

Total affecting conclusions

Favors dossier drug

Favors a competitor

No difference

Other

Unpublished

25

13 (52%)

2 (8.0%)

10 (40%)

2 (8.0%)

Psychiatry topics

31

15 (48%)

6 (19%)

13 (42%)

2 (6%)